Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily.
about
Population analysis of a 24-h paclitaxel infusion in advanced endometrial cancer: a gynaecological oncology group studyEvaluation and comparison of simple multiple model, richer data multiple model, and sequential interacting multiple model (IMM) Bayesian analyses of gentamicin and vancomycin data collected from patients undergoing cardiothoracic surgeryTobramycin disposition in ICU patients receiving a once daily regimen: population approach and dosage simulations.Therapeutic drug monitoring of antimicrobials.Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides.Comparison of gentamicin dose estimates derived from manual calculations, the Australian 'Therapeutic Guidelines: Antibiotic' nomogram and the SeBA-GEN and DoseCalc software programsPopulation pharmacokinetic modelling of gentamicin and vancomycin in patients with unstable renal function following cardiothoracic surgery.Comparison of four renal function estimation equations for pharmacokinetic modeling of gentamicin in geriatric patients.Impact of Introducing Anticoagulation-Related Prescribing Guidelines in a Hospital Setting using Academic Detailing.Assessment of renal function in clinical practice at the bedside of burn patients.Pharmacokinetic modeling of gentamicin in treatment of infective endocarditis: Model development and validation of existing models.Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic studyFour hour creatinine clearance is better than plasma creatinine for monitoring renal function in critically ill patients.Rounding of low serum creatinine levels and consequent impact on accuracy of bedside estimates of renal function in cancer patients.Bayesian Estimation of Tobramycin Exposure in Patients with Cystic Fibrosis.Population pharmacokinetics of ceftazidime in intensive care unit patients: influence of glomerular filtration rate, mechanical ventilation, and reason for admission.Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?Aminoglycoside use in renal failure.Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk.Population pharmacokinetic modelling, Monte Carlo simulation and semi-mechanistic pharmacodynamic modelling as tools to personalize gentamicin therapy.Drug therapy in kidney diseaseClinical decision support implemented with academic detailing improves prescribing of key renally cleared drugs in the hospital setting.Lack of an effect of human immunodeficiency virus coinfection on the pharmacokinetics of entecavir in hepatitis B virus-infected patients.Does the availability of therapeutic drug monitoring, computerised dose recommendation and prescribing decision support services promote compliance with national gentamicin prescribing guidelines?Comparing dose prediction software used to manage gentamicin dosing.A population pharmacokinetic and pharmacodynamic evaluation of pralatrexate in patients with relapsed or refractory non-Hodgkin's or Hodgkin's lymphoma.Population pharmacokinetics of TC-5214, a nicotinic channel modulator, in phase I and II clinical studies.Assessment of aminoglycoside dosing and estimated glomerular filtration rate in determining gentamicin and tobramycin area under the curve and clearance.The performances of the Cockcroft-Gault, modification of diet in renal disease study and chronic kidney disease epidemiology collaboration equations in predicting gentamicin clearance.Impact of various body weights and serum creatinine concentrations on the bias and accuracy of the Cockcroft-Gault equation.Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemia.Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis.We Give Aminoglycoside Antibiotics at the End of Hemodialysis.
P2860
Q30443910-71293BA4-8B97-454E-A41A-B0F0B8E51602Q31144236-08007C72-11C5-437F-9E5D-38CCCDFB0C53Q34476089-2BD96C2E-20FB-494A-9ACC-166B559EFCA8Q35640430-08DF2338-EC3F-4D7D-910C-1FAC7042E84AQ35826231-CA4E679E-7F13-4B4B-BEDB-DBB431059A46Q35826457-B708A4E1-D6B6-4B72-94F2-E0EFD528E158Q35827409-40CDE8CF-A158-4C6C-9377-591288BF91FAQ35867436-A30E8CAF-D7DD-43C0-8B77-15EFA79CB5BFQ35919133-F3C119DA-7DC2-49A1-A331-C0120223054EQ36025095-CA3BB9A1-1C2D-474B-B199-B1328A268B66Q36364337-99DC5FD0-AFBF-4C87-8388-113EAF358363Q36536423-2E39CB0D-1CCB-4206-AC12-68D2787E03D8Q36633733-0745D3CF-D3D4-4076-A1A0-D889C3DBBC1CQ36694636-85D5D839-4582-4A92-91D8-8B35617AB07EQ37358664-2DBCB9A5-3B0B-4967-85FF-4E8CC5B65847Q37392874-F1FE76FD-76D2-4257-A068-BD2A38691A25Q37695055-8A928625-388E-43FC-9AC2-3E087D0E212FQ37808935-2818CA99-B19D-4347-9FAA-45EA7F3061F5Q38090988-49DB7F63-563F-4A23-B521-042AF5F82FE8Q39071799-228E6357-0136-4870-AB89-7AD62D010CA8Q41124878-605E91EE-887C-4EBF-83EC-B8CF18586BBFQ41314653-AA3644C7-44E6-4832-B68D-DC57EA84215EQ41338162-CA7013AD-2DD3-4527-8A62-277AE201431AQ41676743-65B7E72C-19C6-4555-A0D6-5A64E5E7FFE9Q43838579-1CD9B12D-F2FB-4B3C-B9C7-D905CDF9A2C2Q45068216-D4EA861E-D325-404E-8997-B4CD8A9CA1ABQ48373583-5DD8F8DD-0F3A-4706-B335-3919B1165419Q50977991-50A8362E-F8E9-42B8-8A77-5AB1B1062172Q51163450-496B252B-AFB4-4380-BB9C-389765F5B4BBQ51369618-224E1615-08E4-411A-B80B-01083E903EB1Q51458897-9A15280D-F027-41AB-8AEF-C55CA896332BQ51930719-42020EF3-9748-4A2C-B620-97CAF1B05438Q54675401-F291EA45-A759-403E-BAFD-11FC04F38007
P2860
Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Pharmacokinetics of gentamicin ...... nal function dosed once daily.
@ast
Pharmacokinetics of gentamicin ...... nal function dosed once daily.
@en
type
label
Pharmacokinetics of gentamicin ...... nal function dosed once daily.
@ast
Pharmacokinetics of gentamicin ...... nal function dosed once daily.
@en
prefLabel
Pharmacokinetics of gentamicin ...... nal function dosed once daily.
@ast
Pharmacokinetics of gentamicin ...... nal function dosed once daily.
@en
P2860
P1476
Pharmacokinetics of gentamicin ...... enal function dosed once daily
@en
P2093
P2860
P304
P356
10.1046/J.1365-2125.1999.00938.X
P407
P577
1999-06-01T00:00:00Z